Skip to main content

Capula Management Ltd

Position in EW — Edwards Lifesciences Corp

CIK 1557017 Grand Cayman, E9

Position in EW

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$36,836
-$927,125 QoQ
Shares Held
460
-96.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in EW Over Time

Shares Held

Position Value (USD)

Derivatives in EW

reported options exposure · as of Mar 31, 2026
CallValue
$56,056
CallShares
700
PutValue
$192,192
PutShares
2,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Capula Management Ltd holds $60,091,940 across 7 Medical Devices names. EW ranks #7 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 EW
Edwards Lifesciences Corp
This page
460 $36,836

All Filings in EW

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $36,836 460
2026-03-31 $192,192 2,400
2026-03-31 $56,056 700
2022-12-31 $963,961 12,920
2022-09-30 $450,333 5,450
2021-09-30 $920,397 8,130
2021-06-30 $294,345 2,842
2021-03-31 $1,781,532 21,300
2020-12-31 $10,728,648 117,600
2020-12-31 $1,870,215 20,500